dc.contributor.author |
Lazo Porras, María de los Ángeles |
|
dc.contributor.author |
Ruiz-Alejos, A. |
|
dc.contributor.author |
Miranda, J. Jaime |
|
dc.contributor.author |
Carrillo Larco, Rodrigo Martín |
|
dc.contributor.author |
Gilman, Robert Hugh |
|
dc.contributor.author |
Smeeth, L. |
|
dc.contributor.author |
Bernabé Ortiz, Antonio |
|
dc.date.accessioned |
2020-07-14T00:02:30Z |
|
dc.date.available |
2020-07-14T00:02:30Z |
|
dc.date.issued |
2020 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/8320 |
|
dc.description.abstract |
AIM: To determine whether intermediate hyperglycaemia, defined by fasting plasma glucose and HbA1c criteria, is associated with mortality in a 10-year cohort of people in a Latin American country. METHODS: Analysis of the PERU MIGRANT Study was conducted in three different population groups (rural, rural-to-urban migrant, and urban). The baseline assessment was conducted in 2007/2008, with follow-up assessment in 2018. The outcome was all-cause mortality, and the exposure was intermediate hyperglycaemia, using three definitions: (1) impaired fasting glucose, defined according to American Diabetes Association criteria [fasting plasma glucose 5.6-6.9mmol/l (100-125mg/dl)]; (2) prediabetes defined according to American Diabetes Association criteria [HbA1c levels 39-46mmol/mol (5.7-6.4%)]; and (3) prediabetes defined according to the International Expert Committee criteria [HbA1c levels 42-46mmol/mol (6.0-6.4%)]. Crude and adjusted hazard ratios and 95% CIs were estimated using Cox proportional hazard models. RESULTS: At baseline, the mean (sd) age of the study population was 47.8 (11.9) years and 52.5% of the cohort were women. The study cohort was divided into population groups as follows: 207 people (20.0%) in the rural population group, 583 (59.7%) in the rural-to-urban migrant group and 198 (20.3%) in the urban population group. The prevalence of intermediate hyperglycaemia was: 6%, 12.9% and 38.5% according to the American Diabetes Association impaired fasting glucose definition, the International Expert Committee HbA1c -based definition and the American Diabetes Association HbA1c -based definition, respectively, and the mortality rate after 10years was 63/976 (7%). Intermediate hyperglycaemia was associated with all-cause mortality using the HbA1c -based definitions in the crude models [hazard ratios 2.82 (95% CI 1.59-4.99) according to the American Diabetes Association and 2.92 (95% CI 1.62-5.28) according to the International Expert Committee], whereas American Diabetes Association-defined impaired fasting glucose was not [hazard ratio 0.84 (95% CI 0.26-2.68)]. In the adjusted model, however, only the American Diabetes Association HbA1c -based definition was associated with all-cause mortality [hazard ratio 1.91 (95% CI 1.03-3.53)], whereas the International Expert Committee HbA1c -based and American Diabetes Association impaired fasting glucose-based definitions were not [hazard ratios 1.42 (95% CI 0.75-2.68) and 1.09 (95% CI 0.33-3.63), respectively]. CONCLUSIONS: Intermediate hyperglycaemia defined using the American Diabetes Association HbA1c criteria was associated with an elevated mortality rate after 10years in a cohort from Peru. HbA1c appears to be a factor associated with mortality in this Peruvian population. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Wiley |
|
dc.relation.ispartofseries |
Diabetic Medicine |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
hyperglycaemia |
en_US |
dc.subject |
mortality |
en_US |
dc.title |
Intermediate hyperglycaemia and 10-year mortality in resource-constrained settings: the PERU MIGRANT Study |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1111/dme.14298 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.02.18 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.02.27 |
|
dc.relation.issn |
1464-5491 |
|